IBOGAINE Act Initiating Biomedical Outcomes to Garner Advancements...
To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes.
This bill, HB9559, aims to fast-track the development and availability of psychedelic drugs that may treat serious mental illnesses, potentially saving lives and addressing the current crisis. It would affect researchers, patients, healthcare providers, and policymakers by accelerating research and expanding access to innovative treatments.
The bill was introduced on June 30, 2026, and has been referred to the Subcommittee on Health and several other committees for further consideration. It is currently in the early stages of the legislative process.
Key actions so far include its introduction and referral to multiple committees for review. The next steps involve detailed examination and potential amendments before it can advance to a vote.
